BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3467655)

  • 1. [End results and comparative analysis of treatment programs for childhood acute lymphocytic leukemia].
    Kawai S; Fujimoto T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):17-26. PubMed ID: 3467655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia.
    Pui CH; Aur RJ; Bowman WP; Dahl GV; Dodge RK; George SL; Ochs J; Kalwinsky DK; Abromowitch M; Hustu HO
    Cancer Res; 1984 Aug; 44(8):3593-8. PubMed ID: 6589042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Israel national childhood acute lymphoblastic leukemia study].
    Stark B; Abramov A; Attias D; Balin A; Burstein Y; Barak Y; Jaber L; Goshen Y; Dvir A; Hagai E
    Harefuah; 1990 Apr; 118(7):373-82. PubMed ID: 2351344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute leukemia].
    Fujimoto T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):994-1001. PubMed ID: 6471426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
    J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
    Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
    Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of radio-chemotherapy for curing of childhood hematologic tumors: preventive approaches and problems on CNS involvement].
    Fujimoto T
    Gan No Rinsho; 1988 Oct; 34(13):1903-8. PubMed ID: 3199522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of high and low risk acute lymphoblastic leukemias in the child, with 2 modalities of preventive therapy on the central nervous system (Pethema 7/78 protocol)].
    Ortega Aramburu JJ; Javier G; Montagut JM; Torán N
    An Esp Pediatr; 1985 Nov; 23(6):417-30. PubMed ID: 3867301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
    Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children.
    Freeman AI; Weinberg V; Brecher ML; Jones B; Glicksman AS; Sinks LF; Weil M; Pleuss H; Hananian J; Burgert EO; Gilchrist GS; Necheles T; Harris M; Kung F; Patterson RB; Maurer H; Leventhal B; Chevalier L; Forman E; Holland JF
    N Engl J Med; 1983 Mar; 308(9):477-84. PubMed ID: 6571946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
    Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
    Pinkerton CR; Chessells JM
    Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute lymphoblastic leukemia of standard risk: preliminary results obtained with protocol LL-IV-81].
    Verdeguer Miralles A; Castel Sánchez V; Ferris Tortajada J; Esquembre Menor C
    An Esp Pediatr; 1987 Nov; 27(5):325-30. PubMed ID: 3481521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: A Report from Children's Cancer Study Group.
    Nesbit ME; Sather H; Robison LL; Donaldson M; Littman P; Ortega JA; Hammond GD
    Cancer Res; 1982 Feb; 42(2):674-80. PubMed ID: 7034927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.